| CXSB2100006 | 聚乙二醇重组人促红素注射液（CHO细胞） | | Injection | Biological Products(原7) | Supplementary Application | 2021-01-14 | 华润昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | In Review | 2021-01-13 | view |
| CXSL1600127 | 注射用重组人组织型纤溶酶原激酶衍生物 | Recombinant Human Tissue-type Plasminogen Activator Derivative | Lyophilized | Biological Products(1) | New Drug Application | 2017-03-27 | 昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | Certificate Issued | 2017-08-21 | view |
| CXSL1700192 | 注射用重组人组织型纤溶酶原激酶衍生物 | Recombinant Human Tissue-type Plasminogen Activator Derivative | Lyophilized | Biological Products(1) | New Drug Application | 2018-03-12 | 昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | Certificate Issued | 2018-11-19 | view |
| CXSL1900092 | 地特胰岛素注射液 | insulin detemir | Injection | Biological Products(15) | New Drug Application | 2019-08-28 | 华润昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | In Review | 2019-08-27 | view |
| CXSL2000082 | 注射用重组人组织型纤溶酶原激酶衍生物 | Recombinant Human Tissue-type Plasminogen Activator Derivative | Lyophilized | Biological Products(1) | New Drug Application | 2020-05-06 | 华润昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | In Review | 2020-05-01 | view |
| CXSL2100101 | 重组人GLP-1-Fc融合蛋白注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2021-03-23 | 华润昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | In Review | 2021-03-22 | view |
| CXSL2100102 | 重组人GLP-1-Fc融合蛋白注射液 | | Injection | Biological Products(3.3) | New Drug Application | 2021-03-23 | 华润昂德生物药业有限公司 | Shandong E Hua Biology Medicine Co Ltd | In Review | 2021-03-22 | view |
